Yahoo Web Search

Search results

1. • NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business...

     WRBL Columbus· 1 day ago

     Positive data from a Phase 2b/3 trial of NRX-101 in Treatment Resistant Bipolar Depression (TRBD); trial demonstrated depression efficacy comparable to ...

2. • 

     More witnesses take the stand in trial for man accused of killing UA professor

     KVOA Tucson· 2 hours ago

     Wednesday marked day six of the trial for the man accused of shooting and killing UArizona Professor...

3. • 

     How to Deal With the Puppy Blues

     Verywell Mind via Yahoo News· 5 days ago

     If you experience symptoms of depression or severe anxiety, it’s essential to talk to a mental health professional. These feelings can be intense and may...

4. • Mental Health Awareness Month: Supporting older adults

     Nevada Appeal· 7 days ago

     As May marks Mental Health Awareness Month, it's crucial to recognize that mental well-being extends to all ages, including our seniors. The physical, emotional, and cognitive struggles faced ...

5. • Some forms of augmented brain stimulation recommen | Newswise

     Newswise· 22 hours ago

     TMS was approved by the Food and Drug Administration for treatment of MDD in 2008. It uses pulsed magnetic fields to induce an electric current in the left dorsolateral...

6. • 

     4 Your Health: FDA-approved drug aims to help menopausal women with hot flashes, night sweats

     WTAE Pittsburgh· 2 days ago

     Most women know menopause can come with hot flashes and night sweats that can impact sleep and be...

7. • 

     I took magic mushrooms at 76 to treat my depression – and it transformed my life

     The Telegraph via Yahoo News· 6 days ago

     Professor Goodwin has been conducting clinical trials into psilocybin as chief medical officer of a...

8. • 

     Earnings call: COMPASS Pathways reports progress on COMP360 treatment By Investing.com

     Investing.com· 2 days ago

     COMPASS Pathways (CMPS) has provided updates on its COMP360 psilocybin treatment during its first...

9. • US FDA extends review of Ascendis Pharma's hormone disorder therapy

     AOL· 1 day ago

     U.S.-listed shares of the company were down 6.6% in late afternoon trading. The health regulator notified that data submitted for the ongoing review of the therapy, called TransCon PTH, constituted ...

10. • 

      Tackling Gun Violence: Hartford Public Schools provide support for students exposed to trauma

      NBC Connecticut· 5 days ago

      Tackling gun violence is work that Hartford Public Schools educators say they sadly know well. Just...